Literature DB >> 10968428

Ganciclovir resistance: a matter of time and titre.

W L Drew1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968428     DOI: 10.1016/S0140-6736(00)02597-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.

Authors:  Sara Ornaghi; Lawrence S Hsieh; Angélique Bordey; Patrizia Vergani; Michael J Paidas; Anthony N van den Pol
Journal:  J Neurosci       Date:  2017-06-19       Impact factor: 6.167

Review 2.  The search for new therapies for human cytomegalovirus infections.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Virus Res       Date:  2010-11-21       Impact factor: 3.303

3.  Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.

Authors:  Gillian M Scott; Adriana Weinberg; William D Rawlinson; Sunwen Chou
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

Review 4.  The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis.

Authors:  S H James; M N Prichard
Journal:  Infect Disord Drug Targets       Date:  2011-10

Review 5.  Emerging (val)ganciclovir resistance during treatment of congenital CMV infection: a case report and review of the literature.

Authors:  Beatriz Morillo-Gutierrez; Sheila Waugh; Ailsa Pickering; Terence Flood; Marieke Emonts
Journal:  BMC Pediatr       Date:  2017-08-22       Impact factor: 2.125

Review 6.  Cytomegalovirus antiviral stewardship in the COVID-19 Era: Increasing complexity of prophylaxis and treatment and potential mitigation strategies.

Authors:  Margaret R Jorgenson; Jillian L Descourouez; Cynthia Wong; Jill R Strayer; Sandesh Parajuli; John P Rice; Robert R Redfield; Jeannina A Smith; Didier A Mandelbrot; Christopher M Saddler
Journal:  Transpl Infect Dis       Date:  2021-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.